Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2026-02-24 @ 3:51 AM
Study NCT ID:
NCT02129595
Status:
COMPLETED
Last Update Posted:
2017-08-08
First Post:
2014-04-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Sponsor:
Maastricht University Medical Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pre-diabetes | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Resveratrol | View |
| None | Diabetes Mellitus | View |
| None | Diabetes Mellitus, Type 2 | View |
| None | Insulin Resistance | View |
| None | Glucose Metabolism Disorders | View |
| None | Metabolic Diseases | View |
| None | Endocrine System Diseases | View |
| None | Hyperinsulinism | View |
| None | Anti-Inflammatory Agents, Non-Steroidal | View |
| None | Analgesics, Non-Narcotic | View |
| None | Analgesics | View |
| None | Sensory System Agents | View |
| None | Peripheral Nervous System Agents | View |
| None | Physiological Effects of Drugs | View |
| None | Pharmacologic Actions | View |
| None | Anti-Inflammatory Agents | View |
| None | Therapeutic Uses | View |
| None | Antirheumatic Agents | View |
| None | Antineoplastic Agents, Phytogenic | View |
| None | Antineoplastic Agents | View |
| None | Antioxidants | View |
| None | Molecular Mechanisms of Pharmacological Action | View |
| None | Protective Agents | View |
| None | Enzyme Inhibitors | View |
| None | Platelet Aggregation Inhibitors | View |
| None | Hematologic Agents | View |
| None | Antimutagenic Agents | View |
| None | Anticarcinogenic Agents | View |
| None | Central Nervous System Agents | View |
| None | Brown Adipose Tissue | View |